Literature DB >> 9248789

Cefixime absorption kinetics after oral administration to humans.

X D Liu1, L Xie, J P Gao, L S Lai, G Q Liu.   

Abstract

Cefixime (CFX) absorption kinetics after oral administration to humans was studied. Four distinct models, incorporating a delay of absorption and first-order elimination kinetics, i.e. first-order absorption (M1), zero-order absorption (M0), Michaelis-Menten type absorption (MM) and Michaelis-Menten type absorption with 'an absorption window' (MM-delta t) were used to fit concentration data of CFX in 10 Chinese men following an oral dose of 400 mg. r2 and AIC were selected as measures of goodness-of-fit. The results show that the MM-delta t model provided a better fit than the other three models. The kinetic parameters were estimated as follows: Vmax' = 10.80 +/- 3.80 mg.l-1.h-1; K(m)' = 88.31 +/- 2.75 micrograms.ml-1; delta t = 4.75 +/- 0.85 h; T1/2 = 4.20 +/- 0.92 h; Tmax = 5.20 +/- 0.92 h; and Cmax = 6.04 +/- 1.70 mg.l-1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9248789     DOI: 10.1007/BF03189804

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  8 in total

1.  Theoretical model for both saturable rate and extent of absorption: simulations of cefatrizine data.

Authors:  W R Couet; B G Reigner; J P Guedes; T N Tozer
Journal:  J Pharmacokinet Biopharm       Date:  1991-06

2.  Saturable rate of cefatrizine absorption after oral administration to humans.

Authors:  B G Reigner; W Couet; J P Guedes; J B Fourtillan; T N Tozer
Journal:  J Pharmacokinet Biopharm       Date:  1990-02

3.  Relative bioavailability of three cefixime formulations.

Authors:  F Kees; K G Naber; G Sigl; W Ungethüm; H Grobecker
Journal:  Arzneimittelforschung       Date:  1990-03

4.  Analysis of pharmacokinetic data using parametric models. III. Hypothesis tests and confidence intervals.

Authors:  L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1986-10

5.  [A non-linear method and its program for calculating pharmacokinetic parameters].

Authors:  Y C Yang; G Chen; L Yuan
Journal:  Zhongguo Yao Li Xue Bao       Date:  1983-12

6.  Saturable uptake of cefixime, a new oral cephalosporin without an alpha-amino group, by the rat intestine.

Authors:  A Tsuji; H Hirooka; T Terasaki; I Tamai; E Nakashima
Journal:  J Pharm Pharmacol       Date:  1987-04       Impact factor: 3.765

7.  Absolute bioavailability of cefixime in man.

Authors:  R D Faulkner; P Fernandez; G Lawrence; L L Sia; A J Falkowski; A I Weiss; A Yacobi; B M Silber
Journal:  J Clin Pharmacol       Date:  1988-08       Impact factor: 3.126

8.  Determination of cefixime in biological samples by reversed-phase high-performance liquid chromatography.

Authors:  A J Falkowski; Z M Look; H Noguchi; B M Silber
Journal:  J Chromatogr       Date:  1987-11-27
  8 in total
  2 in total

Review 1.  The conduct of drug metabolism studies considered good practice (I): analytical systems and in vivo studies.

Authors:  Xiaodong Liu; Lee Jia
Journal:  Curr Drug Metab       Date:  2007-12       Impact factor: 3.731

Review 2.  The conduct of drug metabolism studies considered good practice (II): in vitro experiments.

Authors:  Lee Jia; Xiaodong Liu
Journal:  Curr Drug Metab       Date:  2007-12       Impact factor: 3.731

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.